Add Yahoo as a preferred source to see more of our stories on Google. A representative image of MM120 ODT, a pharmaceutically optimized form of LSD developed by New York-based MindMed being studied ...
Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety. The results indicate one to two LSD sessions can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results